Herceptin Effective in Breast Cancer Cells With Low HER-2 Levels

monoclonal antibody Herceptin (trastuzumab) used in combination with certain cancer chemotherapies effectively treats breast cancer tumors that produce low or undetectable amounts of the HER-2 oncogene